You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HAQ

Showing 1 - 25 of 1,419
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Perception of Changes in Psychotherapy of Traumatized Young

Not yet recruiting
  • Post-traumatic Stress Disorder
  • Semi-structured interviews
  • +2 more
  • Paris, IDF, France
    University Hospital Cochin, Maison des Adolescents - Youth Depar
Nov 24, 2023

Knowledge of Living Will in Patients With Rheumatic Diseases

Not yet recruiting
  • Rheumatic Disorder
  • Health Assessment Questionnaire (HAQ)
  • +7 more
  • (no location specified)
Jan 6, 2023

Central Sensitization in Familial Mediterranean Fever (FMF)

Recruiting
  • Familial Mediterranean Fever
  • Central Sensitisation
  • Central Sensitization Inventory
  • +6 more
  • Sinop, Turkey
    Feyza Nur Yücel
Jan 3, 2022

Rheumatic Diseases Trial in Kahramanmaras (Bilissel Egzersiz Terapi Yaklasimi (BETY, Cognitive Exercise Therapy Approach))

Completed
  • Rheumatic Diseases
  • Bilişsel Egzersiz Terapi Yaklaşımı (BETY, Cognitive Exercise Therapy Approach)
  • Kahramanmaraş, Turkey
    Nazli Elif Nacar
Mar 24, 2023

Psoriatic Arthritis, Obesity Trial in Ankara (diet and biopsychosocial exercise intervention)

Completed
  • Psoriatic Arthritis
  • Obesity
  • diet and biopsychosocial exercise intervention
  • Ankara, Turkey
    Sümeyra Öteleş
Dec 4, 2022

Fatigue in Patients With Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Determining the relationship of fatigue with some parameters
  • Ankara, Turkey
    Ankara Physical Medicine and Rehabilitation Training and Researc
Aug 17, 2023

Rheumatoid Arthritis, Telehealth Trial in Mexico City (Face-to-face medical visits, Alternating face-to-face medical visits and

Completed
  • Rheumatoid Arthritis
  • Telehealth
  • Face-to-face medical visits
  • Alternating face-to-face medical visits and video medical consultations
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Sep 26, 2022

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

Recruiting
  • Arthritis, Rheumatoid
  • Placebo
  • +2 more
  • Upland, California
  • +2 more
Sep 1, 2023

Physician Consideration of ePRO's, From Gout, Rheumatoid

Not yet recruiting
  • Gout
  • +3 more
  • Therapeutic management following access by the physician to his patient's ePROs
  • (no location specified)
Jun 22, 2023

Systemic Scleroderma Trial in Chelyabinsk, Saint Petersburg (Divozilimab, Placebo)

Recruiting
  • Systemic Scleroderma
  • Chelyabinsk, Russian Federation
  • +2 more
Feb 3, 2023

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Not yet recruiting
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 25, 2023

Patient-reported Outcomes in Polymyalgia Rheumatica

Recruiting
  • Polymyalgia Rheumatica
    • Leuven, Belgium
      University Hospitals Leuven
    Sep 13, 2022

    Systemic, Lupus Trial in Giza (Group A (GA)(Aerobic exercise group), Group B (GB) (Whole-body vibration (WBV) group))

    Enrolling by invitation
    • Systemic
    • Lupus
    • Group A (GA)(Aerobic exercise group)
    • Group B (GB) (Whole-body vibration (WBV) group)
    • Giza, Egypt
      Faculty of Physical Therapy. Cairo University
    Nov 28, 2022

    Rheumatoid Arthritis, Therapy Trial in Jinan (Iguratimod)

    Recruiting
    • Rheumatoid Arthritis
    • Therapy
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 24, 2023

    Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)

    Recruiting
    • Axial Spondyloarthritis
    • Baricitinib 2mg
    • Tofacitinib 5 mg
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    Nov 1, 2023

    Prescription-grade Crystalline Glucosamine Sulfate Therapy in

    Completed
    • Erosive Osteoarthritis of the Hand
    • Glucosamine Sulfate
    • Siena, Italy
      Rheumatology Unit Azienda Ospedaliera Universitaria Senese
    Feb 16, 2022

    Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs

    Completed
    • Arthritis, Rheumatoid
      • Tokyo, Japan
        Pfizer
      Nov 28, 2022

      Rheumatoid Arthritis, Hand Rheumatism Trial in Rzeszów (Kinesiotherapy with magnetotherapy)

      Completed
      • Rheumatoid Arthritis
      • Hand Rheumatism
      • Kinesiotherapy with magnetotherapy
      • Rzeszów, Podkarpackie, Poland
        Laboratorium Czynników Fizykalnych w Rehabilitacji w Przyrodnicz
      Jun 16, 2023

      Rheumatoid Arthritis Trial in Dhaka (Baricitinib 4 MG, Baricitinib 2 MG)

      Recruiting
      • Rheumatoid Arthritis
      • Baricitinib 4 MG
      • Baricitinib 2 MG
      • Dhaka, [Other], Bangladesh
        Dr. Md. Sadikul islam
      Dec 13, 2022

      Outcomes of Participants Taking Inflectra Using CorEvitas

      Active, not recruiting
      • Arthritis, Rheumatoid
      • Collegeville, Pennsylvania
        Pfizer
      Jan 24, 2023

      Myositis Trial in Worldwide (Nipocalimab, Placebo, Glucocorticoids)

      Recruiting
      • Myositis
      • Scottsdale, Arizona
      • +50 more
      Jan 17, 2023

      Dermatomyositis Trial in DeBary (GLPG3667, Placebo)

      Not yet recruiting
      • Dermatomyositis
      • DeBary, Florida
        Omega Research Consultants
      Jan 13, 2023

      Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Treatment target DAS28CRP-LDA
      • Treatment target SDAI-remission
      • (no location specified)
      Sep 13, 2023